SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-19-013155
Filing Date
2019-03-06
Accepted
2019-03-06 17:08:34
Documents
10

Document Format Files

Seq Description Document Type Size
1 425 a18-39904_61425.htm 425 25167
2 GRAPHIC g3990461bgi001.gif GRAPHIC 40078
3 GRAPHIC g3990461bgi002.gif GRAPHIC 129402
4 GRAPHIC g3990461bgi003.gif GRAPHIC 75166
5 GRAPHIC g3990461bgi004.gif GRAPHIC 94179
6 GRAPHIC g3990461bgi005.gif GRAPHIC 58155
7 GRAPHIC g3990461bgi006.gif GRAPHIC 97937
8 GRAPHIC g3990461bgi007.gif GRAPHIC 95667
9 GRAPHIC g3990461bgi008.gif GRAPHIC 70859
10 GRAPHIC g3990461bgi009.gif GRAPHIC 117534
  Complete submission text file 0001104659-19-013155.txt   1100182
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Subject) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-06351 | Film No.: 19663339
SIC: 2834 Pharmaceutical Preparations